U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H21NO2.BrH
Molecular Weight 376.287
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SKF-77434 HYDROBROMIDE

SMILES

Br.OC1=CC2=C(C=C1O)C(CN(CC=C)CC2)C3=CC=CC=C3

InChI

InChIKey=JWQRAXTWDYUBFI-UHFFFAOYSA-N
InChI=1S/C19H21NO2.BrH/c1-2-9-20-10-8-15-11-18(21)19(22)12-16(15)17(13-20)14-6-4-3-5-7-14;/h2-7,11-12,17,21-22H,1,8-10,13H2;1H

HIDE SMILES / InChI

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
19.7 nM [IC50]
PubMed

PubMed

TitleDatePubMed
Effects of chronic administration of the D1 receptor partial agonist SKF 77434 on cocaine self-administration in rhesus monkeys.
2002 Apr
Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists.
2005 Oct
Patents

Patents

Name Type Language
SKF-77434 HYDROBROMIDE
Common Name English
1H-3-BENZAZEPINE-7,8-DIOL, 2,3,4,5-TETRAHYDRO-1-PHENYL-3-(2-PROPEN-1-YL)-, HYDROBROMIDE (1:1)
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID5042611
Created by admin on Sat Dec 16 08:39:39 GMT 2023 , Edited by admin on Sat Dec 16 08:39:39 GMT 2023
PRIMARY
PUBCHEM
11957703
Created by admin on Sat Dec 16 08:39:39 GMT 2023 , Edited by admin on Sat Dec 16 08:39:39 GMT 2023
PRIMARY
CAS
300561-58-4
Created by admin on Sat Dec 16 08:39:39 GMT 2023 , Edited by admin on Sat Dec 16 08:39:39 GMT 2023
PRIMARY
FDA UNII
1C4570NI42
Created by admin on Sat Dec 16 08:39:39 GMT 2023 , Edited by admin on Sat Dec 16 08:39:39 GMT 2023
PRIMARY